Literature DB >> 15637059

SUMO-1 modification of human transcription factor (TF) IID complex subunits: inhibition of TFIID promoter-binding activity through SUMO-1 modification of hsTAF5.

Michaël Boyer-Guittaut1, Kivanç Birsoy, Corinne Potel, Gill Elliott, Ellis Jaffray, Joanna M Desterro, Ron T Hay, Thomas Oelgeschläger.   

Abstract

The TFIID complex is composed of the TATA-binding protein (TBP) and TBP-associated factors (TAFs) and is the only component of the general RNA polymerase II (RNAP II) transcription machinery with intrinsic sequence-specific DNA-binding activity. Binding of transcription factor (TF) IID to the core promoter region of protein-coding genes is a key event in RNAP II transcription activation and is the first and rate-limiting step of transcription initiation complex assembly. Intense research efforts in the past have established that TFIID promoter-binding activity as well as the function of TFIID-promoter complexes is tightly regulated through dynamic TFIID interactions with positive- and negative-acting transcription regulatory proteins. However, very little is known about the role of post-translational modifications in the regulation of TFIID. Here we show that the human TFIID subunits hsTAF5 and hsTAF12 are modified by the small ubiquitin-related modifier SUMO-1 in vitro and in human cells. We identify Lys-14 in hsTAF5 and Lys-19 in hsTAF12 as the primary SUMO-1 acceptor sites and show that SUMO conjugation has no detectable effect on nuclear import or intranuclear distribution of hsTAF5 and hsTAF12. Finally, we demonstrate that purified human TFIID complex can be SUMO-1-modified in vitro at both hsTAF5 and hsTAF12. We find that SUMO-1 conjugation at hsTAF5 interferes with binding of TFIID to promoter DNA, whereas modification of hsTAF12 has no detectable effect on TFIID promoter-binding activity. Our observations suggest that reversible SUMO modification at hsTAF5 contributes to the dynamic regulation of TFIID promoter-binding activity in human cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15637059     DOI: 10.1074/jbc.M414149200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  SUMO functions in constitutive transcription and during activation of inducible genes in yeast.

Authors:  Emanuel Rosonina; Sarah M Duncan; James L Manley
Journal:  Genes Dev       Date:  2010-05-26       Impact factor: 11.361

2.  Direct transactivator-transcription factor IID (TFIID) contacts drive yeast ribosomal protein gene transcription.

Authors:  Justin H Layer; Scott G Miller; P Anthony Weil
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

Review 3.  Promoting developmental transcription.

Authors:  Uwe Ohler; David A Wassarman
Journal:  Development       Date:  2010-01       Impact factor: 6.868

4.  Differential effects of sumoylation on transcription and alternative splicing by transcription elongation regulator 1 (TCERG1).

Authors:  Miguel Sánchez-Álvarez; Marta Montes; Noemí Sánchez-Hernández; Cristina Hernández-Munain; Carlos Suñé
Journal:  J Biol Chem       Date:  2010-03-09       Impact factor: 5.157

5.  Inhibition of DNA binding by differential sumoylation of heat shock factors.

Authors:  Julius Anckar; Ville Hietakangas; Konstantin Denessiouk; Dennis J Thiele; Mark S Johnson; Lea Sistonen
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

6.  The Ulp2 SUMO protease promotes transcription elongation through regulation of histone sumoylation.

Authors:  Hong-Yeoul Ryu; Dan Su; Nicole R Wilson-Eisele; Dejian Zhao; Francesc López-Giráldez; Mark Hochstrasser
Journal:  EMBO J       Date:  2019-07-17       Impact factor: 11.598

7.  Role of noncovalent SUMO binding by the human cytomegalovirus IE2 transactivator in lytic growth.

Authors:  Eui Tae Kim; Young-Eui Kim; Yong Ho Huh; Jin-Hyun Ahn
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

8.  SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.

Authors:  Sam R Holmstrom; Sergey Chupreta; Alex Yick-Lun So; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2008-06-18

9.  Transcriptional regulation of adipogenesis by KLF4.

Authors:  Kivanç Birsoy; Zhu Chen; Jeffrey Friedman
Journal:  Cell Metab       Date:  2008-04       Impact factor: 27.287

10.  SUMO conjugation contributes to immune deviation in nonobese diabetic mice by suppressing c-Maf transactivation of IL-4.

Authors:  Jianmei W Leavenworth; Xiaojing Ma; Yin-yuan Mo; Mary E Pauza
Journal:  J Immunol       Date:  2009-06-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.